Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2007-07-24

FDA Approved: ACTONEL — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Actonel (risendronate sodium) from Allergan, Inc., resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Actonel (risedronate)

Snippet

SUPPL AP for ACTONEL (RISEDRONATE SODIUM)